Literature DB >> 20224878

Minimal change nephrotic syndrome in a patient with strongyloidiasis.

Mieko Miyazaki1, Masahito Tamura, Narutoshi Kabashima, Ryota Serino, Tatsuya Shibata, Tetsu Miyamoto, Yumi Furuno, Tetsuo Nishio, Jiro Ohara, Toshihiro Sakurai, Yutaka Otsuji.   

Abstract

Strongyloidiasis, a chronic infection caused by the intestinal parasite Strongyloides stercoralis, is prevalent in the Nansei Islands of Japan. Here, we report our findings on a case of strongyloidiasis complicated with steroid-resistant minimal change nephrotic syndrome in a 69-year-old male resident of Fukuoka Prefecture who had lived in Yakushima, one of the Nansei Islands, until age 15. In October 2006, he developed proteinuria and edema, and was diagnosed with minimal change nephrotic syndrome on the basis of the renal biopsy findings. Following treatment with prednisolone, the level of proteinuria decreased to 0.29 g/day by day 35. However, 5 days later (day 40), the patient developed persistent watery diarrhea and vomiting, leading to dehydration and malnutrition. Pneumonia and bacterial meningitis subsequently developed (day 146); filarial (infectious-type) and rhabditiform (noninfectious-type) S. stercoralis larvae were detected for the first time in the patient's sputum, gastric juice, feces, and urine. Although treatment with ivermectin was started immediately and the parasitosis responded to the treatment, the patient died of sepsis. Consequently, although strongyloidiasis is a rare infection except in endemic regions, it is essential to consider the possibility of this disease and begin treatment early for patients who have lived in endemic areas and who complain of unexplained diarrhea during steroid-induced or other immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224878     DOI: 10.1007/s10157-010-0273-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  23 in total

Review 1.  Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis.

Authors:  Rafael Igual-Adell; Carlos Oltra-Alcaraz; Enrique Soler-Company; Pilar Sánchez-Sánchez; Josefa Matogo-Oyana; David Rodríguez-Calabuig
Journal:  Expert Opin Pharmacother       Date:  2004-12       Impact factor: 3.889

2.  Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.

Authors:  C S Lam; M K H Tong; K M Chan; Y P Siu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

3.  Minimal change nephrotic syndrome in association with strongyloidiasis.

Authors:  Y P Hsieh; Y K Wen; M L Chen
Journal:  Clin Nephrol       Date:  2006-12       Impact factor: 0.975

4.  Steroid therapy and strongyloidiasis.

Authors:  A J Willis; C Nwokolo
Journal:  Lancet       Date:  1966-06-25       Impact factor: 79.321

5.  Strongyloidiasis as a possible cause of nephrotic syndrome.

Authors:  Y K Yee; C S Lam; C Y Yung; T L Que; T H Kwan; T C Au; M L Szeto
Journal:  Am J Kidney Dis       Date:  1999-06       Impact factor: 8.860

6.  Plasma histamine in patients with chronic renal failure and nephrotic syndrome.

Authors:  D S Gill; V A Fonseca; M A Barradas; R Balliod; J F Moorhead; P Dandona
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

7.  Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.

Authors:  R Bheekha-Escura; D W MacGlashan; J M Langdon; S M MacDonald
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

Review 8.  Renal problems in black South African children.

Authors:  P D Thomson
Journal:  Pediatr Nephrol       Date:  1997-08       Impact factor: 3.714

9.  Strongyloidiasis associated with nephrotic syndrome.

Authors:  S Mori; T Konishi; K Matsuoka; M Deguchi; M Ohta; O Mizuno; T Ueno; T Okinaka; Y Nishimura; N Ito; T Nakano
Journal:  Intern Med       Date:  1998-07       Impact factor: 1.271

Review 10.  Pathology of renal diseases in the tropics.

Authors:  Vijitr Boonpucknavig; Virawudh Soontornniyomkij
Journal:  Semin Nephrol       Date:  2003-01       Impact factor: 5.299

View more
  11 in total

Review 1.  Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease.

Authors:  George Vasquez-Rios; Roberto Pineda-Reyes; Juan Pineda-Reyes; Ricardo Marin; Eloy F Ruiz; Angélica Terashima
Journal:  J Parasit Dis       Date:  2019-02-06

2.  Comment about nephrotic syndrome in association with strongyloidiasis.

Authors:  Gioacchino Li Cavoli; Calogera Tortorici; Luisa Bono; Angelo Ferrantelli; Carlo Giammarresi; Ugo Rotolo
Journal:  Clin Exp Nephrol       Date:  2011-04-06       Impact factor: 2.801

3.  Status of Strongyloidiasis in Japan, 2000-2017.

Authors:  Hiroshi Ikuno; Takashi Ishikawa; Kazumi Norose
Journal:  Am J Trop Med Hyg       Date:  2020-06-18       Impact factor: 2.345

4.  Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report.

Authors:  Tahereh Malakoutian; Ronak Mohammadi; Mojgan Asgari; Atefeh Amouzegar
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

5.  Strongyloides stercoralis infection in transplanted patients.

Authors:  Seyed-Ali Sadjadi; Chitra Damodaran; Mohammad Sharif
Journal:  Am J Case Rep       Date:  2013-06-17

Review 6.  A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review.

Authors:  Ting-Ting Qu; Qing Yang; Mei-Hong Yu; Jie Wang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Disseminated Strongyloidiasis in Association with Nephrotic Syndrome.

Authors:  Amirahwaty Abdullah; Lydia Winnicka; Charumathi Raghu; Violeta Zeykan; Jagmeet Singh
Journal:  Case Rep Nephrol Dial       Date:  2018-08-10

8.  Co-infection with Strongyloides stercoralis hyperinfection syndrome and Klebsiella in a nephrotic syndrome patient: A case report.

Authors:  Wei-Li Wang; Qi-Wu Zhang; Sha Tang; Feng Chen; Jing-Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 9.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

10.  Strongyloides stercoralis-Associated Tip Variant Focal Segmental Glomerulosclerosis.

Authors:  Massini Merzkani; Nupur N Uppal; Daniel W Ross; Pranisha Gautam-Goyal; Prashant Malhotra; Hitesh H Shah; Kenar D Jhaveri; Vivette D D'Agati
Journal:  Kidney Int Rep       Date:  2017-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.